SAM
EPZM

Shell Asset Management’s Epizyme, Inc EPZM Stock Holding History

Shell Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,836
Closed -$172K – 1508
2020
Q4 		$172K Hold
15,836
– – ﹤0.01% 1159
2020
Q3 		$189K Hold
15,836
– – ﹤0.01% 1057
2020
Q2 		$254K Sell
15,836
-138
-0.9% -$2.41K 0.01% 952
2020
Q1 		$248K Sell
15,974
-244
-2% -$5.24K 0.01% 939
2019
Q4 		$399K Sell
16,218
-415
-2% -$6.16K 0.01% 963
2019
Q3 		$172K Sell
16,633
-143
-0.9% -$1.8K ﹤0.01% 1149
2019
Q2 		$211K Sell
16,776
-384
-2% -$4.94K ﹤0.01% 1117
2019
Q1 		$213K Hold
17,160
– – ﹤0.01% 1100
2018
Q4 		$106K Sell
17,160
-1,500
-8% -$11.5K ﹤0.01% 1090
2018
Q3 		$198K Buy
+18,660
New +$213K ﹤0.01% 1101

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Shell Asset Management's EPZM Position: Q1 2021 in Review

Shell Asset Management sold out of Epizyme, Inc (EPZM) in Q1 2021, closing a stake of 15,836 shares — an estimated $172K sold.

Shell Asset Management first reported a position in EPZM in Q3 2018 and held it in 10 quarters. The position peaked at $399K in Q4 2019. 138 funds tracked by Wall St. Rank hold EPZM as of Q1 2021.

  • Shell Asset Management reported no remaining Epizyme, Inc position as of Q1 2021 after selling out during the quarter.
  • Shell Asset Management sold 15,836 Epizyme, Inc shares in Q1 2021, an estimated $172K.
  • Shell Asset Management first reported a position in Epizyme, Inc in Q3 2018 and held it in 10 quarters.
  • Shell Asset Management's Epizyme, Inc position peaked at $399K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2021.

Based on Shell Asset Management's 13F filing for Q1 2021, filed 10 May 2021.